• Earlier in June 2026, Insperity showcased its Insperity HR360, HRCore and HRScale solutions at SHRM26, highlighting how its combined HR service and technology offerings can simplify administration and deepen workforce insights for HR leaders.
• By bringing this integrated HR technology suite to one of the largest HR industry conferences, Insperity directly engaged a concentrated audience of decision-makers who influence adoption of outsourced HR platforms.
• We’ll now examine how Insperity’s SHRM26 launch of its HR360, HRCore and HRScale solutions may reshape the company’s investment narrative.

Find 44 companies with promising cash flow potential yet trading below their fair value.

Insperity Investment Narrative Recap

To own Insperity, you need to believe its combination of high touch HR services and modern platforms like HR360, HRCore and HRScale can deepen relationships with small and mid sized clients while improving profitability. The SHRM26 showcase reinforces the near term catalyst around broader HRScale adoption, but it does not fundamentally change the central risk that healthcare and benefits costs and SMB hiring trends could keep margins under pressure.

The most relevant recent announcement is the February 2026 general availability of Insperity HRScale, built with Workday HCM capabilities. That launch set expectations that HRScale could open a larger mid market opportunity; the June SHRM26 presence now puts those capabilities in front of a dense audience of HR decision makers, which could influence how quickly HRScale and the wider suite contribute to revenue mix and operating leverage.

Yet investors should be aware that rising medical claims and benefits costs could still undermine the value of these new HR offerings if...

Insperity's narrative projects $8.0 billion revenue and $94.5 million earnings by 2029.

Uncover how Insperity's forecasts yield a $40.50 fair value, a 6% upside to its current price.

Exploring Other Perspectives

By contrast, the most pessimistic analysts were modeling only about US$8.2 billion of revenue and roughly US$95.6 million of earnings by 2028, so you should weigh whether HRScale’s success at SHRM26 could challenge that cautious view or reinforce concerns about slower adoption and muted margin recovery.

Explore 4 other fair value estimates on Insperity - why the stock might be worth over 5x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Insperity research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Insperity research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Insperity's overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Explore 30 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.